GSK plc announced it purchased 262,000 ordinary shares on October 1, 2025, as part of its buyback program, with prices ranging from 1,594.50p to 1,670.00p per share. Following this purchase, GSK holds 248,031,844 shares in treasury out of 4,067,375,496 total issued shares.